Jayvant Heera Selected Research

Lamivudine (Epivir)

3/2014	Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings.
3/2010	Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jayvant Heera Research Topics

Disease

6	Infections 01/2019 - 03/2010
4	Hepatitis C 01/2017 - 04/2014
2	HIV Infections (HIV Infection) 06/2015 - 01/2015
2	Hyperbilirubinemia 02/2013 - 11/2010
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 05/2013
1	Hepatitis B 03/2012
1	Inflammation (Inflammations) 10/2010
1	Neoplasms (Cancer) 05/2010

Drug/Important Bio-Agent (IBA)

13	Maraviroc FDA Link 01/2019 - 03/2010
3	efavirenz (Sustiva)FDA Link 03/2014 - 03/2010
2	Anti-Retroviral Agents (Antiretroviral Agents)IBA 11/2015 - 03/2015
2	Lamivudine (Epivir)FDA Link 03/2014 - 03/2010
2	Zidovudine (Retrovir)FDA LinkGeneric 03/2014 - 03/2010
1	Cytochrome P-450 CYP3AIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2015
1	etravirine (TMC-125)FDA Link 09/2014
1	NucleosidesIBA 09/2014
1	Reverse Transcriptase InhibitorsIBA 09/2014
1	UK 453,061IBA 09/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 04/2014
1	Transaminases (Aminotransferases)IBA 02/2013
1	EnzymesIBA 11/2010